🔨 Forge Your Edge Most stocks are noise. I track the ones about to run. RS Leaders. Stage 2 only. Building tools to find them before they move.
Joined April 2026
- Tweets33
- Following15
- Followers12
- Likes22
$SPARC follow up. Days ago this was a cup building into a high tight flag, pivot at 253.17, waiting for volume to confirm the breakout.
It came.
Stock cleared that level and closed near 262, up over 9% on the day. This is still a genuine market leader in an early uptrend, but right now our system says wait, not buy.
Here is why. The stock just ran hard and fast, RSI is hot, and price sits more than 90% above where this base started. That combination means the easy, low-risk entry already happened today. Chasing it here means paying up for a move that has already run.
The good news, the next entries are already mapped on the chart. The 10-day average has held every single pullback through this entire move, six for six. That is the first spot to watch if price cools off. Below that, the 21-day average and the 50-day average are the next lines of defense for the whole trend.
A strong stock proving itself. Patience here, not chasing.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only).
signalsmithlabs.com
#SPARC came up by accident while scrolling through a market we rarely touch. Glad it did.
Vadodara, India. A drug research arm spun off from Sun Pharma years ago, quietly burning cash on a pipeline nobody outside the lab tracked. Net loss of 60 crore rupees as recently as last March.
Then it sold a voucher.
A Priority Review Voucher, the kind the FDA hands out for rare pediatric disease work, went for 195 million dollars. That single sale flipped the quarter to a 1,761 crore rupee profit.
Management kept cutting. US headcount down over 80 percent. Ten million dollars in annual savings targeted. The old dermatology work shelved. What is left is two oncology bets, an antibody drug conjugate called SBO154 and an alopecia candidate called SCD153, both with real data due this year.
Price noticed before the analysts did. Up 78 percent in three months while the broader index went nowhere.
Stage 2 Advancing. RS Rank LEADER. Signal Meter QUALITY.
The chart shows a cup built off a prior 113 percent run, now a high tight flag stacked on top. Entry Type 10 EMA Pullback, Grade A, buy near 234.19, stop 223.39. The bigger trigger sits at the flag pivot, 253.17, on a volume surge.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only).
signalsmithlabs.com
#SPARC came up by accident while scrolling through a market we rarely touch. Glad it did.
Vadodara, India. A drug research arm spun off from Sun Pharma years ago, quietly burning cash on a pipeline nobody outside the lab tracked. Net loss of 60 crore rupees as recently as last March.
Then it sold a voucher.
A Priority Review Voucher, the kind the FDA hands out for rare pediatric disease work, went for 195 million dollars. That single sale flipped the quarter to a 1,761 crore rupee profit.
Management kept cutting. US headcount down over 80 percent. Ten million dollars in annual savings targeted. The old dermatology work shelved. What is left is two oncology bets, an antibody drug conjugate called SBO154 and an alopecia candidate called SCD153, both with real data due this year.
Price noticed before the analysts did. Up 78 percent in three months while the broader index went nowhere.
Stage 2 Advancing. RS Rank LEADER. Signal Meter QUALITY.
The chart shows a cup built off a prior 113 percent run, now a high tight flag stacked on top. Entry Type 10 EMA Pullback, Grade A, buy near 234.19, stop 223.39. The bigger trigger sits at the flag pivot, 253.17, on a volume surge.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only).
signalsmithlabs.com
$FRO follow-up. Ten days ago The Anvil fired an Elite signal at the 52-week high. The question was whether it could clear that level on volume.
It did.
Stage 2 Advancing. RS Rank: LEADER. Signal Meter dropped to QUALITY. Entry Type: WAIT.
Worth showing the full sequence though.
January: first Elite signal. Swing High Breakout. The system was in.
March: two Climax Top warnings into the blow-off bar. Sell Into Strength triggered. The system got out.
Then the pullback. March 13, the 50 SMA held. Entry alert March 23. A second chance was there for those watching.
Ten days ago, the Elite signal again at the highs. Now the price is extended. WAIT means exactly that.
If you entered on that signal, you're sitting on a clean position. Raise your stop to protect the trade. Let it work. No reason to add here.
If you missed it, the system will give you another entry. It always does. Chasing an extended price is how clean trades turn into messy ones.
This is what the system is built for. Not just the entry. The whole sequence.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only). signalsmithlabs.com
$FRO came through the SignalSmith Scanner as the number two Legendary setup today, but the chart hides a better story than a single signal.
THE STORY
Frontline is the largest listed pure play in crude oil tankers, around eighty vessels moving oil across the world's busiest routes. Its earnings live and die on one number, the daily rate to haul a barrel by sea. When the Strait of Hormuz seized up and crude got rerouted onto longer voyages, those rates went vertical. VLCC day rates that sat in the 70 thousands last autumn pushed past 100 thousand by the first quarter, and Frontline printed its strongest quarter since 2004, then raised the dividend.
THE SIGNALS
Back in early January, The Anvil fired an Elite Signal on Frontline. Swing High Breakout near 23.82, five stars, RS already +55% against the market, volume 1.7x. Two more entry signals followed as the stock climbed. The system was in.
Then in early March, it flipped to defense. Two Climax Top warnings printed into a blow-off bar, the largest range and volume in fifty sessions, after a 220% advance off the lows. Sell Into Strength triggered on the same candle. The message was blunt. Do not open new positions, tighten stops, take partials.
That is the whole point. A system that gets you in, then tells you when the move is running hot. Selection, risk control, consistency. Not a crystal ball, a checklist.
THE SETUP NOW
Frontline sold off, found its footing, and pulled all the way back to the 50 SMA. Today it bounced hard, up over five percent, and it is back challenging the 52-week high.
Stage 2 Advancing. RS vs SPY +94%. RS Rank: 97, LEADER. RS Line rising. Five stars on Strength.
RSI 65.1 rising. ADX 14.3.
Signal Meter: LEGENDARY (88). Entry: 50 SMA Pullback. Grade B+.
Buy Near 36.31. Stop 35.11.
Honest read: the cleaner entry was the touch of the 50 SMA last week near 36.31. Today's pop puts price right back under the 52 week high around 40, so it now needs a clean break of that level on volume to go again. The market is still choppy. A leader catching its breath at the highs.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only).
signalsmithlabs.com
$INGM flagged in the SignalSmith Scanner as yesterday's #1 Legendary setup. 91 points. 5 signals across 4 sectors today. This one stood out.
Stage 2 Advancing. RS vs SPY +25.8%. RS Line rising. From Base 15.5%.
Buy Near 28.82. Stop 27.79.
Why is Ingram Micro moving?
Ingram Micro is the backbone of the global IT supply chain. $52.6 billion in annual revenue, reaching nearly 90% of the global population through a network of resellers, cloud providers and technology manufacturers.
The story is changing underneath the surface.
Their AI-powered platform, Xvantage, is converting orders at almost three times normal conversion rates. Cloud guided for double-digit growth in 2026. Q1 2026 net sales hit $14 billion, up 13.7% year over year. Non-GAAP EPS $0.75, up 23% from a year ago. The market is only now starting to price this in.
Base #1 in the advance. If this has legs, this is early.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only).
signalsmithlabs.com
$FRO came through the SignalSmith Scanner as the number two Legendary setup today, but the chart hides a better story than a single signal.
THE STORY
Frontline is the largest listed pure play in crude oil tankers, around eighty vessels moving oil across the world's busiest routes. Its earnings live and die on one number, the daily rate to haul a barrel by sea. When the Strait of Hormuz seized up and crude got rerouted onto longer voyages, those rates went vertical. VLCC day rates that sat in the 70 thousands last autumn pushed past 100 thousand by the first quarter, and Frontline printed its strongest quarter since 2004, then raised the dividend.
THE SIGNALS
Back in early January, The Anvil fired an Elite Signal on Frontline. Swing High Breakout near 23.82, five stars, RS already +55% against the market, volume 1.7x. Two more entry signals followed as the stock climbed. The system was in.
Then in early March, it flipped to defense. Two Climax Top warnings printed into a blow-off bar, the largest range and volume in fifty sessions, after a 220% advance off the lows. Sell Into Strength triggered on the same candle. The message was blunt. Do not open new positions, tighten stops, take partials.
That is the whole point. A system that gets you in, then tells you when the move is running hot. Selection, risk control, consistency. Not a crystal ball, a checklist.
THE SETUP NOW
Frontline sold off, found its footing, and pulled all the way back to the 50 SMA. Today it bounced hard, up over five percent, and it is back challenging the 52-week high.
Stage 2 Advancing. RS vs SPY +94%. RS Rank: 97, LEADER. RS Line rising. Five stars on Strength.
RSI 65.1 rising. ADX 14.3.
Signal Meter: LEGENDARY (88). Entry: 50 SMA Pullback. Grade B+.
Buy Near 36.31. Stop 35.11.
Honest read: the cleaner entry was the touch of the 50 SMA last week near 36.31. Today's pop puts price right back under the 52 week high around 40, so it now needs a clean break of that level on volume to go again. The market is still choppy. A leader catching its breath at the highs.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only).
signalsmithlabs.com
$CVE topped the SignalSmith Scanner this morning as the number one Legendary setup at 89 points, the strongest of seven Legendary signals across five sectors.
Cenovus Energy is exactly the kind of name the scanner is built to surface. A Stage 2 leader, resting.
THE STORY
Cenovus is a Canadian oil sands operator, low cost barrels out of Alberta. Late last year it closed the MEG Energy deal and bolted fresh acreage straight onto its Christina Lake heartland. The redevelopment wells came in ahead of plan. Production hit a record 834,000 BOE a day and management is steering toward a million.
Then oil did the rest. Tension around the Strait of Hormuz put a hard bid under crude, the whole energy patch lifted, and Cenovus ran harder than its peers. Up around 109 percent over the year. Earnings beat. Analysts upgraded.
Now the stock has stopped going up and started to coil.
THE SETUP
Stage 2 Advancing. RS vs SPY +74%. RS Rank: 92, LEADER. RS Line rising. Five stars on Strength.
RSI 47.6. ADX 15.7, the trend is resting, not running.
Signal Meter: LEGENDARY (89). Entry: 50 SMA Pullback. Grade B+.
Buy Near 28.12. Stop 27.17.
Honest read: the broad market is choppy and the contraction is tight. This wants real volume through the descending line near 29.2 to confirm, not a quiet drift higher. Leader resting, finger on the trigger.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only).
signalsmithlabs.com
When $ASTS broke out into the $130s in late May, the Anvil fired Elite Strike #23. Stage 2 Advancing. RS Rank 99, LEADER. Score 74. Pattern: clean breakout on 1.9x volume. But the entry grade said WAIT. Pullback first. Three levels to watch: the 10 EMA, the 21 EMA, the 50 SMA.
That patience is now being tested.
AST SpaceMobile gave back the breakout move into June. Price worked through the 10 EMA. Then through the 21 EMA. Today's low tagged 90.81, just under the 21. Two of the three flagged levels are behind us now. One remains. The 50 SMA at 85.68 is the line that decides whether the breakout was real or premature.
This is exactly what the Anvil's discipline is built for. The signal didn't say buy the high day. It said write down three numbers and wait. Two have been ignored by the market. The third is the test.
If the 50 SMA holds with volume, the setup re-engages and the trend earns the right to continue. If it breaks, the breakout was a Base #0 extension that needed a deeper reset, and walking away costs nothing because we never bought the chase.
RS Rank still LEADER. RS Line still rising. RS vs SPY at +173.8%. The relative strength foundation has not broken even as the price has retraced.
Watching the 50 SMA.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only). signalsmithlabs.com
$STM fired its first Legendary Strike in early February.
At the time, it looked like just another European chipmaker trying to find its footing after a brutal 2025. Revenues down year on year, margins under pressure, the automotive segment missing expectations. Nothing obviously exciting.
But on 9 February, STMicroelectronics signed a multi-year, multi-billion dollar deal with AWS. Not a partnership announcement. A commercial engagement to supply semiconductor technology directly into Amazon's compute infrastructure for AI data centres. The chart had already started moving before most people read the headline.
Then came the sideways phase. Weeks of going nowhere. The kind of price action that shakes out impatient traders and rewards the ones who stay. The Anvil kept watching.
In April, the Power Surge triggered. That signal fires when a stock gains 20% or more in three weeks or fewer from the original entry. O'Neil's 8-week hold rule territory. When a stock moves that fast, you don't sell into it. You hold and let it breathe. STMicroelectronics was doing exactly what a Stage 2 leader does.
Q1 earnings came in on April 23rd. Revenues up 23% year on year, guidance raised, data centre revenues now expected to hit $1 billion in 2026, double the prior target. The trend had a reason.
More signals followed. The RS Line kept rising. LEADER rank on the Anvil. Five stars.
On 2 June, Legendary Strike #105. The data centre ambition raised again. Price extended, Base #2. The Anvil said WAIT, and it was right. Today's session confirms it.
Pullback levels to watch: 10 EMA, 21 EMA, 50 EMA. Worst case, a deeper reset to the 50 EMA would still be healthy trend structure.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only). signalsmithlabs.com
$NWPX update. Flagged April 25 at $82.76.
Trading at $117.76 today. That is +42% in 43 days.
The water infrastructure thesis played out exactly as expected.
Q1 2026 EPS of $1.08 against estimates of $0.59. An 83% beat.
Revenue up 19% year over year. WTS backlog now at $430 million.
Management called 2026 a historic year. The chart agreed before the call did.
Stock is now Base #1 EXTENDED. From Base: 56.8%. Extended.
Entry Type: WAIT. This is not a chase.
If you were in from the April 25 signal, trail your stop.
The move has been significant. Protect it.
RS vs SPY now +172%. Still Stage 2. Still a LEADER.
The trend is intact. But the easy money has been made.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only).
$NWPX update. Flagged here on April 25 at $82.76.
Trading at $113.50 today. That is +37% in 19 days.
Here is what happened in between.
Q1 2026 earnings landed April 29. EPS of $1.08 against expectations of $0.59. An 83% beat. Revenue up 19% year over year. Record gross profit. Record net income. WTS backlog now at $430 million, up from $346 million at year end.
Free cash flow guidance raised. Management said 2026 is shaping up to be a historic year. The chart agreed before the call did.
RSI now at 77.9. ADX 41 and rising. RS vs SPY +150.7%. RS Rank: LEADER. Stage 2 Advancing.
Entry is WAIT. Not a chase. If you were in from the signal, trail your stop.
This is what the scanner finds before the move happens.
The SignalSmith Scanner is coming soon. The Anvil is coming to TradingView.
signalsmithlabs.com
$BWA update. Flagged May 6 at $58.52.
Trading at $72.63 today. That is +24% in 31 days.
The AI data centre angle we mentioned - the turbine generator award targeting $300 million in first-year sales starting 2027, the market is still pricing it in.
Stock pulled back to the 10 EMA twice since the original signal.
Both times it held. Both times it bounced. That is Stage 2 behaviour.
The Anvil now shows ELITE (65). From Base: 40%. Extended.
Entry Type: 10 EMA Pullback. Buy near: 71.84. Stop: 68.92.
If you were in from the original signal, trail your stop.
If you missed it, wait for the next pullback to the 10 EMA.
Do not chase.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only).
$BWA update. Flagged here on May 6 at $58.52.
Trading at $68.47 today. That is +16% in 8 days.
The AI data centre power angle we mentioned? Market is starting to price it in.
RSI 79. ADX 29.9 rising. RS vs SPY +79.3%. RS Rank: LEADER. Still Stage 2.
Entry is now WAIT. Not a chase. If you were in from the signal, trail your stop and let it run.
This is what the scanner finds before the move happens.
The SignalSmith Scanner is coming soon. The Anvil is coming to TradingView.
signalsmithlabs.com
$EWTX flagged by The Anvil. LEGENDARY tier. Entry: WAIT.
Boulder, Colorado. Small biotech with two drugs and a question:
which one is the future?
For years, Edgewise was a muscle disease company. Sevasemten for Becker muscular dystrophy. Phase 3 data coming. Promising. But alongside it, a cardiovascular drug quietly moved through
trials. EDG-7500. Hypertrophic cardiomyopathy. A heart condition that kills people who didn't know they had it.
May 5, 2026. Positive trial data drops. Stock up 22% in a day.
Then June 1, six days ago. Edgewise sells sevasemten and the entire muscular dystrophy business to Servier for $1.55 billion upfront. Up to $2.65 billion total.
They didn't sell because it failed. They sold because EDG-7500 is bigger.
The proceeds fully fund EDG-7500 development through potential FDA approval. No dilution risk. No cash crunch. One company, one drug, one market. Hypertrophic cardiomyopathy affects 1 in 500 people. Most don't know.
RS vs SPY +121.9%. RS Rank: LEADER. 5 stars.
Stage 2 Advancing. Base #1 EARLY. From Base: 19.8%.
Signal Meter: 78%. LEGENDARY (89). Entry Type: WAIT.
Watching for the entry.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only).
$BCBP flagged by The Anvil. LEGENDARY tier. Swing High Breakout.
Bayonne, New Jersey. Community bank. $3.2 billion in assets.
For three years, the bank drifted into the wrong places. Cannabis real estate loans. Small business loans are marketed as "Business Express." Both sounded fine on paper. Neither worked out.
2025: $43 million in charge-offs. Q4 alone — a $12 million loss. The previous CEO was gone by May 20. No fanfare.
The board called Thomas O'Brien.
48 years in banking. Six turnarounds. His last job was at Sterling Bancorp in Michigan — a bank that pleaded guilty to a $69 million securities fraud. O'Brien walked in, stabilised it, and sold it. That's what he does.
June 1, 2026. His first investor call. He said he wanted to get out in front of the story. Identify the problem loans, ring-fence them, and tell the market exactly what he sees. No dragging it out. "The faster, the better."
Q1 2026 already showed the turn. Net income $4.9 million. EPS $0.26. A year ago, it was a loss of $0.51 per share. Loan loss provisions fell from $20.8 million to $2.8 million. Stock still trades at 50-60% of book value. O'Brien knows it. That's the target.
The Anvil:
LEGENDARY (90). RS Rank: STRONG. RS Accel: Improving. Base #1 EARLY. Entry Type: WAIT. Watching for the entry.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only).
Weekly view.
Three years of decline visible in one chart. Death crosses, lower highs, lower lows. Stock fell from $15 to $8.
Golden Cross in late 2025. Then the volume spike in Q1 2026 when earnings turned positive. Now breaking above the 200 SMA for the first time in years.
This is what a turnaround looks like on a chart before
most people notice it.
1
25
$JNJ flagged by The Anvil. QUALITY tier. 10 EMA Pullback. Grade A.
Stock pulled back from Feb highs and is now bouncing off the 10 EMA in Stage 2. Base #0 EARLY. From Base: 5.6%. Not extended.
The Anvil:
Signal Meter 70%. QUALITY (91). Grade A.
Buy near: 227.91. Stop: 223.35.
Why is Johnson & Johnson moving?
The company just closed its biggest chapter in years. Stelara, once its flagship drug generating billions annually, lost patent protection. Wall Street braced for a cliff. It never came.
Q1 2026: sales $24.1B, up 9.9%. DARZALEX growing 18%, TREMFYA up 64%. Two new drug approvals. Full year guidance raised. 64th consecutive year of dividend increases.
JP Morgan called it "one of the cleaner names in the group."
Stock sold off after earnings. Classic. Now it's setting up on the 10 EMA.
Buy near: 227.91. Stop: 223.35.
Not a trade rec. Do your own work.
The Anvil by Signal Smith. Now on TradingView (invite-only).
$NDLS flagged in the SignalSmith Scanner as a 10 EMA Pullback in a confirmed Stage 2 name.
Noodles & Company is a fast-casual turnaround story that is no longer asking you to believe. Q1 2026 delivered: comps up 9.1%, Adjusted EBITDA up 218% year over year, guidance raised. Sixteen consecutive months of positive same-store sales. The plan is now showing up in the numbers.
The Anvil dashboard: RSI 61.8. ADX 36.9. Stage 2 Advancing. RS vs SPY +90.8%. RS Rank: LEADER. 5 stars on Strength. Signal Meter: 90%. Tier: LEGENDARY. Entry: 10 EMA Pullback. Grade A.
Buy Near: 12.42. Stop: 11.55. Base #0 Extended, 17.8% from base.
The risk: tight balance sheet, $106M debt, strategic review unresolved. This is a turnaround, not a blue chip.
But the chart and the fundamentals are saying the same thing right now.
Not a trade rec. Do your own work.
The SignalSmith Scanner is coming soon. The Anvil is coming to TradingView.
signalsmithlabs.com
$AUPH flagged in the SignalSmith Scanner as a 50 SMA Pullback in a Stage 2 name.
Aurinia Pharmaceuticals is a profitable, cash-generating biotech with a single dominant product: LUPKYNIS for lupus nephritis. Q1 2026 revenue up 24% year over year. Net income up 48%. Full-year guidance reaffirmed. The new CEO just bought above 10% stake. Pipeline expanding via Kezar Life Sciences acquisition.
The Anvil dashboard: RSI 61.1. ADX 13.2. Stage 2 Advancing. RS vs SPY +77.6%. RS Rank: LEADER. 5 stars on Strength. Signal Meter: 81%. Tier: LEGENDARY. Entry: 50 SMA Pullback. Grade B+.
Buy Near: 15.61. Stop: 15.02. Next earnings: late July.
Clean window. No binary events for 8 weeks.
Not a trade rec. Do your own work.
The SignalSmith Scanner is coming soon. The Anvil is coming to TradingView. signalsmithlabs.com #ForgeYourEdge
#KEN did not sit flat. It was already making its first moves.
The Anvil flagged the initial signal in January as Stage 2 started forming. Then came the retest. Lower risk, structure holding, volume confirming. More signals. Then the breakout through resistance with conviction.
Each entry is placed at a logical point in that sequence. Not at the top of a move. At the beginning of the next one.
From those early signals, Kendrick Resources ran RS vs SPY +3971%. From base: 283.1%. RS Rank: LEADER the entire way.
That is what reading structure early looks like in practice.
The Anvil is coming to TradingView.
signalsmithlabs.com
#ForgeYourEdge
$BRUN broke out on volume and The Anvil was ready.
The moment institutional activity showed up in the price structure, the dashboard started flagging entries. Stage 2 Advancing confirmed. ADX rising. RS Line breaking out against the market. Each signal placed at a logical level, each one with a defined stop.
Not a guess. A process.
The stock ran 291% from its 52w low from there.
RSI 79.4. ADX 51. RS vs SPY: +255.6%. RS Rank: LEADER. From base: 268.8%.
The Anvil does not predict. It reads what the market is already telling you and puts you in position before the move gets obvious.
That is the difference between early and late.
The Anvil is coming to TradingView. signalsmithlabs.com
$INVX update. Flagged here on May 14 at $27.21 as a Cup and Handle.
Trading at $29.64 today. That is +8.9% in 4 days. New 52w high.
The cup is completed. The handle broke. The move is underway.
RSI 72.4 rising. ADX 28.6 rising. RS vs SPY +73.6%. RS Rank: LEADER. Stage 2 Advancing. Squeeze still on, 4 bars building.
But price is now knocking on resistance. This is the moment that separates traders from gamblers.
If you are in from the signal, this is where you think about partial profits. Take some off the table at resistance, let the rest run with a trailed stop. If it breaks through with volume, the next leg could be significant. If it rejects, you protected gains.
The 10 EMA Pullback entry is live at $27.80. Stop $26.87. New entries wait for the break or the pullback.
Not a trade rec. Do your own work.
The SignalSmith Scanner is coming soon. The Anvil is coming to TradingView.
signalsmithlabs.com
$INVX flagged by The Anvil as a Cup and Handle. Ranked #1 in the SignalSmith Scanner today out of 695 signals.
Stock up 103% from its 52-week low. Stage 2 Advancing. RS vs SPY +52.8%. RS Rank: STRONG. Signal Meter: 86%. Tier: LEGENDARY. Entry: 10 EMA Pullback. Grade A. Squeeze building: 2 bars in.
The Cup and Handle is one of the cleanest continuation patterns in swing trading. Long base, tight handle, controlled pullback. Price coiling before the next move.
Why is Innovex International moving?
Born from the 2024 merger of Dril-Quip and Innovex Downhole Solutions, this is a subsea and downhole technology company with a capital-light model and no bank debt. Q1 2026 results beat the high end of guidance on both revenue and EBITDA. Adjusted EBITDA margin came in at 21%, ahead of expectations. Cash on hand: $201 million. The balance sheet has no leverage.
In the quarter, the company won two subsea projects in Asia each exceeding $20 million, secured a contract extension in Saudi Arabia, and landed the first subsea wellhead order in Southeast Asia under the OneSubsea alliance. Significant orders are building for late 2026 and into 2027.
This is an oilfield services company that grows market share even in a softer macro environment. The chart noticed before most people did.
Buy near: $27.21. Stop: $26.30.
Not a trade rec. Do your own work.
The SignalSmith Scanner is coming soon. The Anvil is coming to TradingView.
signalsmithlabs.com
$INVX flagged by The Anvil as a Cup and Handle. Ranked #1 in the SignalSmith Scanner today out of 695 signals.
Stock up 103% from its 52-week low. Stage 2 Advancing. RS vs SPY +52.8%. RS Rank: STRONG. Signal Meter: 86%. Tier: LEGENDARY. Entry: 10 EMA Pullback. Grade A. Squeeze building: 2 bars in.
The Cup and Handle is one of the cleanest continuation patterns in swing trading. Long base, tight handle, controlled pullback. Price coiling before the next move.
Why is Innovex International moving?
Born from the 2024 merger of Dril-Quip and Innovex Downhole Solutions, this is a subsea and downhole technology company with a capital-light model and no bank debt. Q1 2026 results beat the high end of guidance on both revenue and EBITDA. Adjusted EBITDA margin came in at 21%, ahead of expectations. Cash on hand: $201 million. The balance sheet has no leverage.
In the quarter, the company won two subsea projects in Asia each exceeding $20 million, secured a contract extension in Saudi Arabia, and landed the first subsea wellhead order in Southeast Asia under the OneSubsea alliance. Significant orders are building for late 2026 and into 2027.
This is an oilfield services company that grows market share even in a softer macro environment. The chart noticed before most people did.
Buy near: $27.21. Stop: $26.30.
Not a trade rec. Do your own work.
The SignalSmith Scanner is coming soon. The Anvil is coming to TradingView.
signalsmithlabs.com